The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
Abstract
A nationwide survey of 4325 dialysis facilities was conducted at the end of 2013, among which 4268 (98.7%) responded. The number of new dialysis patients was 38 095 in 2013. Since 2008, the number of new dialysis patients has remained almost the same without any marked increase or decrease. The number of dialysis patients who died in 2013 was 30 751. The dialysis patient population has been growing every year in Japan; it was 314 438 at the end of 2013. The number of dialysis patients per million at the end of 2013 was 2470. The crude death rate of dialysis patients in 2013 was 9.8%. The mean age of new dialysis patients was 68.7 years and the mean age of the entire dialysis patient population was 67.2 years. The most common primary cause of renal failure among new dialysis patients was diabetic nephropathy (43.8%). The actual number of new dialysis patients with diabetic nephropathy has almost been unchanged for the last few years. Diabetic nephropathy was also the most common primary disease among the entire dialysis patient population (37.6%), followed by chronic glomerulonephritis (32.4%). The percentage of dialysis patients with diabetic nephropathy has been increasing continuously, whereas the percentage of dialysis patients with chronic glomerulonephritis has been decreasing. The number of patients who underwent hemodiafiltration (HDF) at the end of 2013 was 31 371, a marked increase from that in 2012. This number is more than twice that at the end of 2011 and approximately 1.5 times the number at the end of 2012. In particular, the number of patients who underwent online HDF increased approximately fivefold over the last 2 years. Among 151 426 dialysis patients with primary causes of renal failure other than diabetic nephropathy, 10.8% had a history of diabetes. Among those with a history of diabetes, 26.8% used glycoalbumin as an indicator of blood glucose level; and 33.0 and 27.6% were administered insulin and dipeptidyl peptidase (DPP)–4 inhibitor, respectively, as a medication of diabetes. The facility survey showed that 9392 patients underwent peritoneal dialysis (PD). The patient survey revealed that 1920 of these PD patients also underwent another dialysis method using extracorporeal circulation, such as hemodialysis (HD) or HDF. The number of patients who underwent HD at home at the end of 2013 was 461, a marked increase from that at the end of 2012 (393).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maximum utilization of the life table method in analyzing survival
Cutler, S. J., & Ederer, F. (1958) · Journal of Chronic Diseases · doi:10.1016/0021-9681(58)90126-7 · Cited by 2,870
Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008)
Nakai, S., Suzuki, K., Masakane, I., Wada, A., Itami, N., Ogata, S., Kimata, N., Shigematsu, T., Shinoda, T., Syouji, T., et al. (2010) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2010.00893.x · Cited by 222
Self-citationOverview of Regular Dialysis Treatment in Japan (as of 31 December 2009)
Nakai, S., Iseki, K., Itami, N., Ogata, S., Kazama, J. J., Kimata, N., Shigematsu, T., Shinoda, T., Shoji, T., Suzuki, K., et al. (2012) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2011.01050.x · Cited by 100
Self-citationBest Practice for Diabetic Patients on Hemodialysis 2012
Nakao, T., Inaba, M., Abe, M., Kaizu, K., Shima, K., Babazono, T., Tomo, T., Hirakata, H., Akizawa, T., & Japanese Society for Dialysis Therapy (2015) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12299 · Cited by 76
Cited by
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy
Thurlow, J. S., Joshi, M., Yan, G., Norris, K. C., Agodoa, L. Y., Yuan, C. M., & Nee, R. (2021) · American Journal of Nephrology · doi:10.1159/000514550 · Cited by 855
Robinson, B. M., Akizawa, T., Jager, K. J., Kerr, P. G., Saran, R., & Pisoni, R. L. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30448-2 · Cited by 415
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho
Yamada, S., & Giachelli, C. M. (2017) · Bone · doi:10.1016/j.bone.2016.11.012 · Cited by 316
The heart and vascular system in dialysis
Wanner, C., Amann, K., & Shoji, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30508-6 · Cited by 303
Metadata
- Authors
- Masakane, I., Nakai, S., Ogata, S., Kimata, N., Hanafusa, N., Hamano, T., Wakai, K., Wada, A., & Nitta, K.
- Venue
- Therapeutic Apheresis and Dialysis
- Publisher
- Wiley
- Published
- 2015-12
- Volume
- 19
- Issue
- 6
- Pages
- 540-574
- ISSN
- 1091-6660 (ISSN-L)
- 1744-9979
- 1744-9987
- OpenAlex
- W2218839371
- Cited by
- 425
- References
- 4
- FWCI
- 49.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013). https://app.cochat.ai/papers/10.1111/1744-9987.12378
- The paper
- Masakane, I., Nakai, S., Ogata, S., Kimata, N., Hanafusa, N., Hamano, T., Wakai, K., Wada, A., & Nitta, K. (2015). An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013). Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.12378
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.